Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
OBI-999 by OBI Pharma for Esophageal Cancer: Likelihood of Approval
OBI-999 is under clinical development by OBI Pharma and currently in Phase II for Esophageal Cancer. According to GlobalData, Phase...
OBI-999 by OBI Pharma for Gastric Cancer: Likelihood of Approval
OBI-999 is under clinical development by OBI Pharma and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...
OBI-999 by OBI Pharma for Solid Tumor: Likelihood of Approval
OBI-999 is under clinical development by OBI Pharma and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
OBI-999 by OBI Pharma for Colorectal Cancer: Likelihood of Approval
OBI-999 is under clinical development by OBI Pharma and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase...
OBI-999 by OBI Pharma for Pancreatic Cancer: Likelihood of Approval
OBI-999 is under clinical development by OBI Pharma and currently in Phase II for Pancreatic Cancer. According to GlobalData, Phase...